CVD risk (≥15%) | ||||||||
---|---|---|---|---|---|---|---|---|
Serum 25(OH)D quartiles (nmol/L) | Q1 (<43.4) | Q2 (43.4–58.6) | Q3 (58.7–74.2) | Q4 (≥74.3) | ||||
Overall | 20–59 (y) | Ref | 0.78 | 0.60, 1.02 | 0.93 | 0.70, 1.23 | 0.65* | 0.47, 0.92 |
≥60 (y) | Ref | 0.99 | 0.89, 1.09 | 0.89* | 0.80, 0.99 | 0.82* | 0.73, 0.92 | |
a Mexican Americans | 20–59 (y) | Ref | 0.70 | 0.49, 1.01 | 0.80 | 0.50, 1.27 | 0.75 | 0.44, 1.29 |
≥60 (y) | Ref | 0.93 | 0.79, 1.10 | 0.92 | 0.78, 1.08 | 0.81 | 0.63, 1.03 | |
a Non-Hispanic Whites | 20–59 (y) | Ref | 0.70 | 0.48, 1.02 | 0.89 | 0.62, 1.29 | 0.61* | 0.40, 0.93 |
≥60 (y) | Ref | 1.01 | 0.88, 1.16 | 0.90 | 0.79, 1.04 | 0.82* | 0.74, 0.97 | |
a Non-Hispanic Blacks | 20–59 (y) | Ref | 1.03 | 0.75, 1.43 | 0.97 | 0.69, 1.37 | 0.51 | 0.19, 1.40 |
≥60 (y) | Ref | 0.88 | 0.75, 1.04 | 0.86 | 0.71, 1.04 | 0.63* | 0.45, 0.88 |